6618 — JD Health International Cashflow Statement
0.000.00%
- HK$115.83bn
- HK$64.81bn
- CNY58.16bn
- 90
- 35
- 91
- 86
Annual cashflow statement for JD Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -17,235 | -1,073 | 383 | 2,143 | — |
Depreciation | |||||
Non-Cash Items | 18,051 | 2,241 | 2,168 | 629 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2,856 | 2,199 | 3,213 | 1,606 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,699 | 3,431 | 5,905 | 4,605 | — |
Capital Expenditures | -38.8 | -518 | -2,273 | -69.3 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -7,804 | -17,234 | -1,963 | -7,954 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7,843 | -17,752 | -4,236 | -8,023 | — |
Financing Cash Flow Items | -219 | -75 | -8.85 | -14.3 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 32,029 | -164 | -925 | -117 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 27,306 | -15,018 | 1,465 | -3,681 | — |